Subscribe
istock-657489382-obencem
Obencem / iStockphoto.com
6 September 2018Americas

Novartis sells portions of Sandoz US portfolio to Aurobindo

Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Novartis launches Nerve platform to harness ‘data revolution’
3 July 2018   Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.
Americas
Novartis acquires gene therapy company
18 May 2018   Novartis has acquired clinical-stage gene therapy company AveXis.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Novartis launches Nerve platform to harness ‘data revolution’
3 July 2018   Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.
Americas
Novartis acquires gene therapy company
18 May 2018   Novartis has acquired clinical-stage gene therapy company AveXis.

More on this story

Big Pharma
Novartis launches Nerve platform to harness ‘data revolution’
3 July 2018   Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.
Americas
Novartis acquires gene therapy company
18 May 2018   Novartis has acquired clinical-stage gene therapy company AveXis.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility